MetaTrader
  • Mercati
  • Grafici & Idee
  • Algo
  • Notizie
  • Store
  • Broker
  • Scarica
  • Calendario Economico
  • Segnali di Trading
  • Terminale Web
  • English English
  • Русский Русский
  • 中文 中文
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Entera Bio Ltd. Ordinary Shares

ENTX

#3415
Entera Bio Ltd. Ordinary Shares
1.39
-8.55%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
1.39
1.39
Intervallo Annuale
1.00
3.22
Variazione giornaliera
-8.55%
Variazione Mensile
-11.46%
Variazione di 6 mesi
-30.15%
Variazione Annuale
-27.60%
Chiusura Precedente
1.52
Open
1.39
Bid
Ask
Low
1.39
High
1.39
Volume
2
  1. Mercati
  2. Mercato Azionario Statunitense
  3. Salute
  4. ENTX
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

Notizie

Benzinga Benzinga
ENTX
2026.02.19
What Pushed Entera Bio (ENTX) To Rally Nearly 16% After Hours - Entera Bio (NASDAQ:ENTX)
Investing Investing
OPK CLGN ENTX
2026.02.10
H.C. Wainwright reitera calificación de Compra para acciones de Opko Health
Investing Investing
OPK ENTX
2026.02.10
Opko Health stock rating reiterated at Buy by H.C. Wainwright
Investing Investing
ENTX
2026.02.09
Entera Bio nombra a Geno Germano como presidente de la junta directiva
Investing Investing
ENTX
2026.02.09
Entera Bio appoints Geno Germano as board chairman
Investing Investing
OPK ENTX
2026.02.04
OPKO y Entera amplían colaboración para desarrollar tratamiento oral de PTH
Investing Investing
ENTX
2026.02.04
OPKO and Entera expand collaboration to develop oral PTH treatment
Investing Investing
ENTX
2026.01.21
Entera Bio planea presentar su medicamento para osteoporosis a la FDA en el primer trimestre de 2026
Investing Investing
ENTX
2026.01.21
Entera Bio planea presentar solicitud a la FDA para fármaco de osteoporosis en 1T 2026
Investing Investing
ENTX
2026.01.21
Entera Bio plans FDA submission for osteoporosis drug in Q1 2026
Investing Investing
ENTX
2025.12.24
H.C. Wainwright mantiene recomendación de Compra para Entera Bio tras validación de FDA
Investing Investing
ENTX
2025.12.24
H.C. Wainwright mantiene calificación de Compra para Entera Bio tras validación de la FDA

Mercati

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Grafici & Idee

  • Idee di Trading
  • Idee Educative
  • Grafici

MQL5 Community

  • Market
  • Segnali
  • Forum
  • Articoli
  • CodeBase

Notizie

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Broker

  • Tutti i Broker
  • Forex
  • Azioni
  • Metalli
MetaTrader 5
MQL5 Channels
Economic Calendar
Esclusione di Responsabilità e Informativa sui Rischi Termini di Utilizzo Contatti e richieste Legale
Copyright 2000-2026, MetaQuotes Ltd